Northern Trust Corp Taysha Gene Therapies, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,372,525 shares of TSHA stock, worth $2.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,372,525

Previous 270,766 406.9%

Holding current value

$2.76 Million

Previous $606,000 355.12%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.01 - $2.46 $2.21 Million - $2.71 Million	1,101,759 Added 406.9%	1,372,525 $2.76 Million
Q2 2024 Aug 14, 2024	BUY	$2.04 - $4.17 $121,116 - $247,577	59,371 Added 28.09%	270,766 $606,000
Q1 2024 May 14, 2024	SELL	$1.43 - $3.25 $3,326 - $7,559	-2,326 Reduced 1.09%	211,395 $606,000
Q4 2023 Feb 13, 2024	BUY	$1.33 - $2.88 $196,216 - $424,889	147,531 Added 222.89%	213,721 $378,000
Q3 2023 Nov 13, 2023	SELL	$0.63 - $3.66 $4,263 - $24,770	-6,768 Reduced 9.28%	66,190 $209,000
Q4 2022 Feb 13, 2023	BUY	$1.39 - $2.98 $45,913 - $98,432	33,031 Added 82.73%	72,958 $164,000
Q3 2022 Nov 14, 2022	BUY	$1.76 - $4.94 $1,946 - $5,463	1,106 Added 2.85%	39,927 $77,000
Q2 2022 Aug 12, 2022	SELL	$2.47 - $6.77 $412,005 - $1.13 Million	-166,804 Reduced 81.12%	38,821 $144,000
Q1 2022 May 13, 2022	SELL	$5.22 - $11.86 $48,780 - $110,831	-9,345 Reduced 4.35%	205,625 $1.34 Million
Q4 2021 Feb 08, 2022	BUY	$11.43 - $19.2 $34,770 - $58,406	3,042 Added 1.44%	214,970 $2.5 Million
Q3 2021 Nov 15, 2021	BUY	$15.82 - $21.57 $206,751 - $281,898	13,069 Added 6.57%	211,928 $3.95 Million
Q2 2021 Aug 13, 2021	BUY	$19.29 - $26.38 $1.97 Million - $2.69 Million	101,935 Added 105.17%	198,859 $4.22 Million
Q1 2021 May 12, 2021	SELL	$20.3 - $31.75 $128,580 - $201,104	-6,334 Reduced 6.13%	96,924 $1.97 Million
Q4 2020 Feb 11, 2021	BUY	$19.14 - $28.13 $1.98 Million - $2.9 Million	103,258 New	103,258 $2.74 Million

Others Institutions Holding TSHA

# of Institutions

119

Shares Held

136M

Call Options Held

25.9K

Put Options Held

24K

View Full List

About Taysha Gene Therapies, Inc.

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $97.2M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

More about TSHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Taysha Gene Therapies, Inc. Transaction History